Article
Ototoxicity from Combined Cisplatin and Radiation Treatment: An In Vitro Study
1 Jan 2010
Abstract excerpt
Objective. Combined cisplatin (CDDP) and radiotherapy is increasingly being used to treat advanced head and neck cancers. As both CDDP and radiation can cause hearing loss, it is important to have a better understanding of the cellular and molecular ototoxic mechanisms involved in combined therapy. Procedure. The effects of CDDP, radiation, and combined CDDP-radiation on the OC-k3 cochlear cell line were studied...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
